Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Oct;49(3):179-209.
doi: 10.1016/j.jinf.2004.05.018.

A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines

Affiliations
Review

A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines

David B Huang et al. J Infect. 2004 Oct.

Abstract

Viral vaccines could be considered among the most important medical achievements of the 20th century. They have prevented much suffering and saved many lives. Although some curative antiviral drugs exist, we desperately depend on efforts by academic, governmental and industrial scientists in the advancement of viral vaccines in the prevention and control of infectious diseases. In the next decade, we hope to see advancement in the development of current and investigational viral vaccines against childhood and adult infections. In this article, we will review the licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Eczema vaccinatum. (Reprinted from Mucocutaneous Manifestations of Viral Diseases, 2002, Figs. 3–13, page 47 by courtesy of Marcel Dekker, Inc.).
Figure 2
Figure 2
Pustule on the lower eyelid secondary to autoinoculation of vaccinia. (Photograph courtesy of Roberto Arenas, MD, Mexico City, Mexico) (Reprinted from Mucocutaneous Manifestations of Viral Diseases, 2002, Figs. 3–11, page 47 by courtesy of Marcel Dekker, Inc.).

Comment in

  • Licensed viral vaccines.
    Arya SC, Agarwal N. Arya SC, et al. J Infect. 2005 May;50(4):367. doi: 10.1016/j.jinf.2004.11.009. J Infect. 2005. PMID: 15845441 No abstract available.

Similar articles

Cited by

References

    1. Brundtland G.H. State of the world's vaccines and immunizations. JAMA. 2002;288:2532. - PubMed
    1. CDC Measles update—measles activity through week 52 (ending Dec 28, 2002) Natl Immunization Program. 2003;3:1–4.
    1. Henderson D.A., Moss B. Smallpox and vaccinia. In: Plotkin S.A., Orenstein W.A., editors. Vaccines. WB Saunders Company; London: 1999. pp. 74–97.
    1. Sepkowitz K.A. How contagious is vaccinia? N Engl J Med. 2003;348:439–446. - PubMed
    1. Lane J., Goldstein J. Evaluation of 21st-century risks of smallpox vaccination and policy options. Ann Intern Med. 2003;138:488–493. - PubMed